House votes to repeal Obamacare tax once seen as key to health law

18 July 2019 - In the heat of the legislative fight over the Affordable Care Act, Obama administration officials argued ...

Read more →

LifeMax receives rare paediatric disease designation for LM-030 for the treatment of Netherton syndrome

18 July 2019 - LifeMax Laboratories today announced that the FDA granted rare paediatric disease designation to LM-030, an investigational therapy ...

Read more →

Part D beneficiaries may pay more for some generics, biosimilars than brand name drugs

16 July 2019 - Medicare Part D enrolees may actually pay more for some generic drugs than they would for their ...

Read more →

On drug prices, Trump must resist left-wing approaches that would lead to disaster

17 July 2019 - In Friday's column, I explained why President Donald Trump and the Republicans are on their way ...

Read more →

Car shopping, handbags and wealthy uncles: the quest to explain high drug prices

17 July 2019 - High drug prices are a hot topic in politics right now. President Trump has made lowering ...

Read more →

Durect announces that the FDA agreed to file the full response to the Posimir complete response letter as a complete Class 2 resubmission

17 July 2019 - User fee goal date is 27 December 2019. ...

Read more →

Trump to order drive for improved flu vaccine

16 July 2019 - President Donald Trump is readying an executive order that would direct HHS to overhaul the development ...

Read more →

U.S. FDA accepts Allergan's new drug application for bimatoprost sustained release in patients with open-angle glaucoma or ocular hypertension

17 July 2019 - Filing included data from the Phase 3 ARTEMIS studies, which demonstrated that the majority of patients remained ...

Read more →

FDA approves Merck’s Recarbrio (imipenem, cilastatin, and relebactam) for the treatment of adults with complicated urinary tract and complicated intra-abdominal bacterial infections where limited or no alternative treatment options are available

17 July 2019 - Merck  today announced that the U.S. FDA has approved Recarbrio (imipenem, cilastatin, and relebactam) for injection, 1.25 ...

Read more →

Kamala Harris introduces plan to lower prescription drug prices

16 July 2019 - Senator Kamala Harris unveiled a plan Tuesday to lower prescription drug prices if she's elected president. ...

Read more →

LogicBio Therapeutics receives rare paediatric disease designation for LB-001 for the treatment of methylmalonic acidaemia

16 July 2019 -  LogicBio Therapeutics today announced the U.S. FDA has granted rare paediatric disease designation to LB-001, a ...

Read more →

How pharma, under attack from all sides, keeps winning in Washington

16 July 2019 - It does not seem to matter how angrily President Trump tweets, how pointedly House Speaker Nancy ...

Read more →

Price increases of protected-class drugs in Medicare Part D, relative to inflation, 2012-2017

16 July 2019 - In recent years, the Centers for Medicare & Medicaid Services has considered allowing greater flexibility in ...

Read more →

Ask whether a drug works before worrying about what it costs

16 July 2019 - Last week was supposed to be a turning point for drug price transparency.  ...

Read more →

Kamala Harris wants the federal government to set the price of some drugs to lower costs

16 July 2019 - Democratic presidential candidate Kamala Harris unveiled a plan on Tuesday that authorises the federal government to ...

Read more →